• 1
    Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893917.
  • 2
    Sant M, Allemani C, Santaquilani M, et al.; EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009; 45: 93191.
  • 3
    Dassen AE, Lemmens VE, van de Poll-Franse LV, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010; 46: 110110.
  • 4
    Van Cutsem E, Dicato M, Geva R, et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 2011; 22( Suppl 5): v19.
  • 5
    Oncoline. Utrecht: Comprehensive Cancer Centre the Netherlands; c2011. Dutch guideline for gastric carcinoma. Available at:, accessed March 14, 2012.
  • 6
    Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology (ICD-O), 3rd edn. Geneva: World Health Organization (WHO), 2000.
  • 7
    Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
  • 8
    Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005; 23: 711424.
  • 9
    Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 1120.
  • 10
    Hølmebakk T, Frykholm G, Viste A; Norwegian Gastrointestinal Cancer Group (NGICG). Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: a retrospective audit. Eur J Surg Oncol 2010; 36: 6106.
  • 11
    Hartgrink HH, Putter H, Klein Kranenbarg E, et al.; Dutch Gastric Cancer Group. Value of palliative resection in gastric cancer Br J Surg 2002; 89: 143843.
  • 12
    National Clinical Audit Support Programme (NCASP). Leeds: The NHS Information Centre for health and social care; c2012. National oesophago-gastric cancer audit 2010. Available at:, accessed June 13, 2012.
  • 13
    Smith JK, Hill JS, Ng SC, et al. Potential benefit of resection for stage IV gastric cancer: a national survey. J Gastrointest Surg 2010; 14: 16608.
  • 14
    Mahar AL, Coburn NG, Singh S, et al. A systematic review of surgery for non-curative gastric cancer. Gastric Cancer, in press.
  • 15
    Allum WH, Blazeby JM, Griffin SM, et al.; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2011; 60: 144972.
  • 16
    Hartgrink HH, Jansen EP, van Grieken NC, et al. Gastric cancer. Lancet 2009; 374: 47790.
  • 17
    Reid-Lombardo KM, Gay G, Patel-Parekh L, et al.; Gastric Patient Care Evaluation Group from the Commission on Cancer. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from the National Cancer Data Base. J Gastrointest Surg 2007; 11: 4109; discussion 419–20.
  • 18
    Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 112837.
  • 19
    Learn PA, Bach PB. A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care 2010; 48: 10419.
  • 20
    Jensen LS, Nielsen H, Mortensen PB, et al. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol 2010; 36( Suppl 1): S504.
  • 21
    Thompson AM, Rapson T, Gilbert FJ, et al.; Scottish Audit of Gastric and Oesophageal Cancer. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg 2007; 94: 57884.